• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The invention is related to improved nucleic acid reagents comprising arrays of nucleic acid fragments and combinations of such fragments. The preparation of such fragments by recombinant DNA techniques and their use in sandwich hybridization methods is also described. By making different combinations of the nucleic acid fragments-some labeled and some affixed to solid carriers, it is possible to create kits for the identification of e.g. veneral diseases. The improved nucleic acid reagents comprise two series of at least two alternating nucleic acid fragments, which are homologous to sequences in the nucleic acid to be identified, one of the series being labeled and one affixed to a solid carrier. Nucleic acid fragments belonging to different series must not be homologous to each other. Sandwich hybridization tests performed with arrays of nucleic acid fragments are at least four times as sensitive as sandwich hybridization tests performed with reagents belonging to the prior art.
    公开号:SU1523053A3
    申请号:SU853856877
    申请日:1985-02-15
    公开日:1989-11-15
    发明作者:Марьятта Палва Аири；Марьют Ранки Туула；Эрик Седерлунд Ханс
    申请人:Орион-Ихтюмя Ой (Фирма)；
    IPC主号:
    专利说明:

    The invention relates to molecular genetics and concerns the identification of viruses and bacteria by sandwich hybridization.
    The aim of the invention is to increase the sensitivity of the method.
    Determination of detection sensitivity of Chlamydia cytomegalo-virus. herpes simplex virus, human papilloma virus, is provided by using a series of alternating nucleic acid fragments deposited on a solid carrier and labeled reagents.
    Example 1. DNA fragments suitable for the diagnosis of the Chlamydia trachomatie group are prepared from Chlamydia trachomatis serotype L dacs. 2. This DNA is extracted and fragmented by known methods, the resulting DNA fragments are cloned into the plasmid pBR322 and transferred to the organism of Escherichia coll K12 HBlOl by known methods. As a result of this cloning, a gene bank of Chlamydia trachomatis L 2 bacteria is obtained, i.e. a large number of recombinant plasmids are obtained, each of which has a separate restriction fragment of Wat HI from J. Chlamydia. To obtain a reagent from the gene bank, recombinant plasmids containing the largest inserts of DNA obtained from chlamydial DNA. One such plasmid is designated pCTN1220, which has been deposited at the Center for Cultural Collections of the Deutsche Sannnlung von Microorganismen under the number (DSM2825), and which is suitable for use as a resp.
    00
    p sd
    with
     cm
    agents are demonstrated by direct hybridization. The test showed that pCTN1220 identifies all nucleic acids from different Chlamydia trachomatis serotypes, but does not identify any other nucleic acids.
    Fragments obtained using various restriction endonucleases receive plasmids from DNA and some of these fragments are transferred, after subsequent cloning into plasmid pAT153, and some into K13 phage. Fragments belonging to series B are used as labeled samples. of these fragments and vectors used for subsequent cloning, the names of recombinant plasmids and their use,
    The fragments shown in Table 1 are separated from the agarose gel by electroelution and cloned into the corresponding restriction sites of the vectors listed in Table 1, using already known methods.
    A fragment of BamKl-BamHl 2, square is obtained as follows. BamHl Sall 1.4 KB and Sal I-Bam K I 0.7 KB fragments of the pCTH1220 plasmid were separated by agarose gel electrophoresis gel, from which they were extracted. Purified fragments were bound to each other by the T4 ligase enzyme, and from DNA fragments 2, kv, obtained in this reaction, those who have free ends of Wat HI,. Additionally, they are associated with the limit point of the Wat HI of the double molecular strand of phage DNA M13 shr 8.
    In this way, recombinant phac-DNA (inKTH 245) is obtained, containing Chlamydia trachomatis DNA, which includes two separate DNA fragments that are not located directly next to each other in this genome. However, in this genome, they are located adjacent to pCTN1250 and pCTN1254 DNA reagents that are associated with the filter.
    A study was made of the sensitivity of a number of nucleic acids as reagents in comparison with a continuous pair of reagents using the sandwich hybridization method. This test is carried out using filters, each of which contains 10 molecules of both pCTN 250 (a) and

    rKCT1252 (a) DNA in the form of a single; medical thread. The sample under study is the plasmid pKTI 1220, which in this test is stretched into one strand at boiling for 5 min in 0.17 M NaOH, after which the temperature is lowered to 0 ° C and neutralized with an equal amount of acetic acid, In this test, use the following samples labeled 125ts - listed in Table. 1: (b), TKTN1239 (b), inKTH1248 (b) and TKTN1245 ().
    Hybridization is carried out for 17 hours in a hybridization solution having the following composition: 4 x X SS C, 0.02% Ficoll, 0.02% polyvinyl pyrrolidone. Oh, 2% sodium dodedyl sulfonate (SDS) and 200 µg / ml of herring sperm DNA. Filters were run for 2 hours at 50 ° C with a spray solution having the following composition: 0.1 x SSC, 0.2% SDS, and counted using a gamma counter. The results are shown in Table. 2 and each result is the average of five parallel tests.
    It is statistically calculated that the 95% allowable limit of tests carried out without a sample (negative control) is considered as the lower limit of positivity. These values are 52-54 ots / min, when the sample is b i i 58 ots / min, when the sample is b. 56-samp / min when the sample is b, and 65-samp / min when the sample is (. Bj.
    Example 2. Samples taken from three men suffering from urethritis and three women suffering from cervicitis are selected for testing. Chlamydia trachomotis is taken from the urethra of men, female samples are taken from the cervix of women. In addition, a study of the corresponding number of similar samples of patients from whom chlamydia is not selected is given. Samples to be examined are sampled using cotton-tipped swabs, which are immersed in a buffer solution with a dissolved chlamydia sample containing 0.2 M sucrose, 20 mK phosphate buffer. 3% calf fetal pod.
    20
    25
    10 μgAm of gentamicin, 100 μg / ml of vancomycin and 25 units / pc of nystatin.
    Chlamydia from these samples are cultivated. Initial samples are also analyzed by sandwich hybridization using a number of nucleic acid fragments. These samples are concentrated using 2-butanol for removal. of these, the fluids are such that the final volume is about 80 µl, and thus the concentration of these samples for testing increases by about 3-7 times. After that, 70 mM ethylenediaminetetraacetic acid (EDTA), 0.7% sodium dodecyl sulfate (SDS), 20 µg / ml of K proteinase enzyme are introduced into the sample and processed for 15 minutes at 55 ° C and 45 minutes at 37 ° C. After that, the sample is boiled for 5 minutes in 0.175 M NaOH. The boiled sample is cooled to 0 ° C. and neutralized with an equal amount of acetic acid and subjected to testing. In the test, the filters in the hybridization condition described in Example 1 are used. The sample used is a TKTN 1245 () 300,000 counts / min. 400 µl of the hybridization solution. The hybridization results are presented in Table. 3
    The limit of positivity in these trials is 104 counts / min.
    The results cited in. 3 shows that sandwich hybridization, carried out using a number of nucleic acid fragments, is suitable for the diagnosis of venereal diseases. Samples that were negative during culture testing were also negative in sandwich hybridization testing.
    Example 3 DNA fragments suitable for the diagnosis of cytomegalosus are prepared from cytomegalo virus (AD169, ATCC VR-538) - (CMV), the DNA is isolated and fragmented by known methods. A fragment of 1 E coRI lina of approximately 9 kv is recovered from the agarose gel by electroelution after the EcoRI fragments are separated based on their size. Lyuirovannuyu DNA is extracted with pheno, after which it is precipitated with ethanol. thus purified DNA is bound by T-4 ligase with the vector
    15
    thirty
    35
    40
    45
    50
    55
    0
    five

    The plasmids pB 325, an EcoRI-treated enzyme, the resulting recombinant DNA is transferred to a E. coli K12 HBIOI bacterial host. Among the ampicillin-resistant and tetracycline-resistant but chloramphenicol-sensitive clones, one that contains a cytomegalovirus-specific DNA insert of the required size is chosen. The nature of the cytomegalovirus cloned DNA is determined by the method of applying Southern spots. This test shows that the 9 kV EcoRI-DNA fragment 5 described was obtained from cytomegalovirus DNA and, in particular, it is included in its Hind III D fragment. The described recombinant plasmid is designated rKTH127 and is deposited at the Center of the Deutsche Sammlung von Microorganis crop collection. - men under the number DSM 2826.
    Subsequent cloning was carried out by already known methods using the plasmid pB 322 and the phage K13 tr7 and C13 tprV as vectors. A number of nucleic acid fragments are prepared using restrictive fragments E coRI, Bam HI, Cla I and Pst I, In Table. Figure 4 shows the sizes of these fragments and the vectors used for further cloning, and the names of the recombinant plasmids thus formed and their use either as filter reagents or as labeled samples.
    0
    five
    0
    five
    0
    five
    Investigate the sensitivity of a number of nucleic acids as reagents in comparison with a continuous pair of reagents using the sandwich hybridization method. The test specimen in this case is DNA DNA (cytomegalovirus DNA), which is boiled in 0.17 K NaOH for 5 minutes and then neutralized, as in Example 1, in this test filters are used, each of which contains molecules as PKTN1273 (a,) DNA, and pCTN1274 (a.) DNA, in the form of single-stranded molecules, and the following samples, labeled 125, listed in Table. 4: tKTN1277 (btKTN1278 (bg) and TN1.279 (C). Each of the samples contains 10 samples / min / µg of DNA. Hybridization is carried out as described in Example 1, the results are shown in Table 5;
    in this test, the lower limit of positivity is counts / min when the sample is b. B2. or b 59 samples / min when the sample is b ,, b and 63 samples / min when the sample is b bj.
    The results in Table 5 show that sandwich hybridization, in which individual
    reagent sample (b
    or
    Bz)
    at
    Reagents in hybridization testing
    35
    in each case, it detects 4x106 molecules of CM V DNA. On the other hand, pKTCH 1273 (a,) and
    pKTN1274 (a) on the filters ITKT1277 (b), tKTN1278 (bJ, wKTH1279 (b) as samples, each 200,000 samples / min per reaction. In other cases, the hybridization, washing and counting of the results are carried out as described in Example 1,
    The results of this hybridization are given in table. 6
    The results presented in Table 6 show that using a variety of nucleic acids as reagents, cytomegalovirus can be detected from various clinical samples, such as urine, lung biopsy samples and cells.
    This test is specific for cytomegalovirus, it does not identify human DNA, i.e. This test does not interfere with the human DNA present in the test sample. In fact, the type of sample does not affect the specificity of this test.
    权利要求:
    Claims (1)
    [1]
    Invention Formula
    A method for identifying viruses and bacteria based on sandwich-hybridizing nucleic acids, including contacting a nucleic acid sample with a first nucleic acid fragment deposited on a solid carrier with a reagent, and a second nucleic acid fragment labeled with a reagent, followed by radioactive analysis that distinguishes - so that, in order to increase the sensitivity of the method, when identifying bacteria of the genus Chlamydia, two series of alternating nucleic acid fragments are taken, and as reagents, on solid carrier, use Glal-Sal I fragments of 3.0 KB and Sal I-Cla I of 2.9 KB of plasmid pKTH1220, subcloned into the vector pAT153,
    Ridization performed with the reagent (b, b or b, b) detects only 10 cMv DNA molecules. These results show that the range of nucleic acids, as reagents, 20 is four times more sensitive than individual. Nucleic acids, as reagents.
    Clinical samples are analyzed by sandwich hybridization with 25 using a number of reagents. These samples include two urine samples taken from children up to one year old. These children suffer from congenital large red blood cells (CMV). A HIV hybridization method also analyzed a sample taken by lung biopsy from a patient with infectious pulmonary cytomegalovirus (SLE). As samples, in this test, human 3Ar310 cells infected and not infected with cytomegalovirus are also used.
    A solution containing% sarkosyl and 5 mK of ethylenediaminetetraacetic acid and 200 µg of DNA from the calf goiter gland is injected into a 10 ml urine sample, after which DNA extracted from the virus, together with the carrier, is precipitated using 10 ml of isopropanol at room temperature. The precipitated DNA is dissolved in 200 µl of TE buffer solution and converted into the form of a single-stranded molecule by boiling for 5 minutes, after which the DNA solution is cooled to 0 ° C and introduced into the hybridization solution.
    A lung biopsy specimen (a few MM) is mechanically crushed with a knife and 200 µl of IE buffer solution containing dodecyl sulfate (1% / 51a.ta sodium (SDS) and 1 mg / ml K proteinase enzyme) is added to it. for 1 h
    40
    45
    50
    0538
    at which time the specimen is passed twice into the syringe to inject the thin subcutaneous needle. The sample homogenized in this way is boiled, after which it is introduced into the test solution.
    Cells infected with cytomegalovirus and non-infected cells destroy Q by the action of sodium dodecyl sulfate and K proteinase, homogenize and boil as described above.
    Reagents in hybridization testing
    5 represent pCTN 1273 (a,) and
    , j labeled reagents are Sal I - Bam HI fragments of 0.7 KB, Bam HI - Sal I of 1.4 KB and Cla I - Cla I of 1.7 KB of plasmid pKTH1220, subcloned into phage Ml 3 mp8 , the Sal I - Bam HI and Bam HI - Sal I fragments are stitched together with the formation of the 2.1 KB Bcim HI - Bam HI fragment, while identifying the cytomegalovirus with FAR I - Pst I supported reagents 3.3 KB size and Cla I-Bam HI size 3.0 KB of plasmid pKTH1271, subcloned into pBR 322 vector; a Pst I – Pst I fragment of 0.6 KB of plasmid pKHTl271 was used as labeled reagents, sub cloned into plasmid M13 tr7, and JQ Pst I - Cla I fragments with a size of 1.0 KB and Bam HI-EcpR I with a size of 1.0 KB of the plasmid pKTH 1271, subcloned into M13mp8 phage, when identifying herpes simplex viruses of type 1 as reagents , 25 deposited on a solid carrier, using two EcoRI-Pst I fragments of 1.1 kV and two Pst I-Bam HI fragments of a 1.5 KB plasmid
    pCTN1359 subcloned into the phages M13 mplO and M13tp11, and the Hind III - EcoR I fragment with the size 1.9 KB of the plasmid pCTT 1359, subcloned into the plasmid pBR325, fragments of Pst I-Pst I with size 1.8 KB and Hind III - Bam HI size 1.3 KB of the plasmid pKTH G359, subcloned into the plasmid pBR322,
    Q Q 5
    0
    five
    and in identifying type 2 herpes simplex viruses, two Hind Ill-Pst I fragments with a size of 2.0 KB and two Pst I-Hind III fragments with a size of I, 2 KB of the plasmid rKTH135, subcloned into phages, are used as reagents on a solid carrier. M13TP 10 and MI3mp 1I, and as labeled reagents, a Pst I – Pst I fragment with a size of 5.7 KB of the pCTB 1351 plasmid, subcloned to the pBR322 plasmid, and with an additional one, is used. Identification of human papiloma virus type 11-CHV 11 as reagents applied to a solid carrier, use two fragments of Wat Hl-Pst I 1.4 kV in size, two fragments of Psti I-Pst I 0.8 kV in size and two fragments of Pst I-Pst I of 0.9 kV of the HPV genome 11, subcloned into phages M13 fflp 10 and K13 mp 11, and in the labeled reagents used two fragments of Pst I - Pst I of 1.7 kV and 1.5 kV of the human papilloma genome type 11, subcloned into the plasmid pBR 322, and in the identification of human papilloma virus type 16 as reagents applied to solid spruce, using two fragments of Pst I - Pst I with the size of 1.7-KB and 1.1 KB of the HPV 16 genome, subcloned into phage M13tp 10, and the fragment of Wat HI - Pst I with the size of 2.7 KB and 0.5 KB of the genome of human papiloma virus type 16, subcloned into the plasmid RVI 322.
    Table 1
    eleven
    1523053
    B ;, - 380000 sh / min / test; 5-10 ots / min / µg DNA
    Ъ2 - 340000otch / min / test; 4-10 otsch / min / mkg DNA
    B, - 350000otch / min / tested; ots / min / µg DNA}
     - 310000otch / min / test; 7-10 otsch / min / mkg DOC;
    B, b - 700000otch / min / test;
    (s, -b) bs-700,000t / min / test
    Table 3
    12
    6lit2
    TableA
    35 38 85 203
    B
    310000 sh / min / test;
    320000 sh / min / test;
    300000 sh / min / test;
    300,000 sh / min / each test;
    3 300000 sh / min of each test,
    1 Table 6
    38 46 142 265
    45 95 205 415
    53 125 292 645
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1523053A3|1989-11-15|Method of identifying viruses and bacteria, based on sandwitch-hybridization of nucleic acids
    Matthews et al.1987|The cloning of chromosomal DNA associated with methicillin and other resistances in Staphylococcus aureus
    Barbour et al.1987|Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends
    Roberts et al.1984|Serological relationships and genome homologies among geminiviruses
    Andoh et al.1968|Suppressor gene Su3+ of E. coli, a structural gene for tyrosine TRNA.
    Ezoe et al.1981|Degradation of intracellular DNA in KB cells infected with cyt mutants of human adenovirus type 12
    Hung et al.1999|Development of a rapid method for the diagnosis of citrus greening disease using the polymerase chain reaction
    Dickin et al.1989|Hybridisation with a repetitive DNA probe reveals the presence of small chromosomes in Trypanosoma vivax
    Katz et al.1991|Identification of three gene regions associated with virulence in Dichelobacter nodosus, the causative agent of ovine footrot
    EP0336412A2|1989-10-11|Synthetic oligonucleotides useful for the determination of Chlamydia trachomatis in a biological sample
    McLaughlin et al.1986|Detection of Babesia bovis Using DNA Hybridization 1
    Stenger et al.1988|Isolation, molecular cloning, and detection of strawberry vein banding virus DNA
    Araki et al.1981|A T7 amber mutant defective in DNA-binding protein
    Rosner et al.1984|Diversity of citrus tristeza virus strains indicated by hybridization with cloned cDNA sequences
    DE4110962A1|1992-10-08|EQUINE HERPESVIREN | CONTAINING FOREIGN DNA, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN Vaccines
    Vogel et al.1990|Echinococcus multilocularis: characterization of a DNA probe
    Silva et al.1988|A basic replicon of virulence-associated plasmids of Shigella spp. and enteroinvasive Escherichia coli is homologous with a basic replicon in plasmids of IncF groups
    Bergström et al.1992|Extrachromosomal elements of spirochetes
    Benkö et al.1990|Molecular cloning and physical mapping of the DNA of bovine adenovirus serotype 4; study of the DNA homology among bovine, human and porcine adenoviruses
    US7329407B2|2008-02-12|Recombinant herpesvirus and polyvalent vaccine
    Keam et al.1991|Detection of infectious laryngotracheitis virus in chickens using a non-radioactive DNA probe
    EP0547446B1|1998-04-29|Vaccines based on modified bovine herpesvirus type I
    Qhobela et al.1990|Evidence that Xanthomonas campestris pv. zeae can be distinguished from other pathovars capable of infecting maize by restriction fragment length polymorphism of genomic DNA
    US4831125A|1989-05-16|DNA probe for corynebacterium kutscheri
    Ray et al.1984|Phosphate repression of phage protein synthesis during infection by choleraphage φ149
    同族专利:
    公开号 | 公开日
    FI71768B|1986-10-31|
    DE3505287A1|1985-09-05|
    BE901671A|1985-05-29|
    SE463103B|1990-10-08|
    LU85768A1|1985-07-24|
    AU3842285A|1985-08-22|
    SE8500733D0|1985-02-15|
    ATA44185A|1991-10-15|
    DE3505287C2|1994-01-20|
    GB2156074B|1988-03-16|
    HU194938B|1988-03-28|
    NL193663B|2000-02-01|
    DK174675B1|2003-08-25|
    FI840655A|1985-08-18|
    NO850554L|1985-08-19|
    JPS60188100A|1985-09-25|
    CH671778A5|1989-09-29|
    US4731325A|1988-03-15|
    IT8519432D0|1985-02-07|
    FR2559783B1|1990-03-02|
    IT1183184B|1987-10-05|
    NL8500424A|1985-09-16|
    RO92633B|1987-10-31|
    NO166543B|1991-04-29|
    DK58985A|1985-08-18|
    GB8503900D0|1985-03-20|
    NL193663C|2000-06-06|
    FI71768C|1987-02-09|
    AT394578B|1992-05-11|
    DK58985D0|1985-02-08|
    IE850202L|1985-08-17|
    IE57652B1|1993-02-10|
    GB2156074A|1985-10-02|
    HUT37459A|1985-12-28|
    NO166543C|1991-08-07|
    CA1248895A|1989-01-17|
    AU577568B2|1988-09-29|
    RO92633A|1987-10-30|
    JPH0463679B2|1992-10-12|
    ZA85511B|1985-11-27|
    SE8500733L|1985-08-18|
    FI840655A0|1984-02-17|
    FR2559783A1|1985-08-23|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US4366246A|1977-11-08|1982-12-28|Genentech, Inc.|Method for microbial polypeptide expression|
    US4293652A|1979-05-25|1981-10-06|Cetus Corporation|Method for synthesizing DNA sequentially|
    FI63596C|1981-10-16|1983-07-11|Orion Yhtymae Oy|MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER|
    GB8306426D0|1983-03-09|1983-04-13|Malcolm A D B|Detecting polynucleotide sequence|
    CA1260372A|1984-04-27|1989-09-26|Elazar Rabbani|Hybridization method for the detection of geneticmaterials|
    US4563417A|1984-08-31|1986-01-07|Miles Laboratories, Inc.|Nucleic acid hybridization assay employing antibodies to intercalation complexes|CA1260372A|1984-04-27|1989-09-26|Elazar Rabbani|Hybridization method for the detection of geneticmaterials|
    US4725536A|1985-09-19|1988-02-16|Genetics Institute, Inc.|Reagent polynucleotide complex with multiple target binding regions, and kit and methods|
    US4876187A|1985-12-05|1989-10-24|Meiogenics, Inc.|Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences|
    US4910300A|1985-12-11|1990-03-20|Chiron Corporation|Method for making nucleic acid probes|
    US4868105A|1985-12-11|1989-09-19|Chiron Corporation|Solution phase nucleic acid sandwich assay|
    US4882269A|1985-12-13|1989-11-21|Princeton University|Amplified hybridization assay|
    FI76119C|1986-02-27|1988-09-09|Orion Yhtymae Oy|Quantitative determination of nucleic acid molecules and reagent packaging used in the process|
    US4925785A|1986-03-07|1990-05-15|Biotechnica Diagnostics, Inc.|Nucleic acid hybridization assays|
    DE3789597T3|1986-05-01|2006-10-26|Washington Research Foundation, Seattle|IDENTIFICATION OF CHLAMYDIA'S INDIVIDUAL TREATMENT ASSOCIATED WITH RESPIRATORY DISEASES.|
    US5281518A|1986-05-01|1994-01-25|Washington Research Foundation|Detection of a unique chlamydia strain associated with acute respiratory disease|
    US5202231A|1987-04-01|1993-04-13|Drmanac Radoje T|Method of sequencing of genomes by hybridization of oligonucleotide probes|
    US6270961B1|1987-04-01|2001-08-07|Hyseq, Inc.|Methods and apparatus for DNA sequencing and DNA identification|
    US5124246A|1987-10-15|1992-06-23|Chiron Corporation|Nucleic acid multimers and amplified nucleic acid hybridization assays using same|
    CA1339351C|1987-10-15|1997-08-26|Michael S. Urdea|Nucleic acid multimers and amplified nucleic acid hybridization assays using same|
    US5359100A|1987-10-15|1994-10-25|Chiron Corporation|Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers|
    CA1323293C|1987-12-11|1993-10-19|Keith C. Backman|Assay using template-dependent nucleic acid probe reorganization|
    US5700637A|1988-05-03|1997-12-23|Isis Innovation Limited|Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays|
    US7811751B2|1988-05-03|2010-10-12|Oxford Gene Technology Limited|Analysing polynucleotide sequences|
    GB8810400D0|1988-05-03|1988-06-08|Southern E|Analysing polynucleotide sequences|
    US6054270A|1988-05-03|2000-04-25|Oxford Gene Technology Limited|Analying polynucleotide sequences|
    AT144556T|1988-06-24|1996-11-15|Amgen Inc|METHOD AND MEANS FOR DETECTING NUCLEIC ACID SEQUENCES|
    US5185243A|1988-08-25|1993-02-09|SyntexInc.|Method for detection of specific nucleic acid sequences|
    DE69006126T2|1989-02-03|1994-08-18|Eastman Kodak Co|NUCLEIC ACID TESTING MATERIAL AND ITS APPLICATION FOR DETECTING A PRE-DETERMINED NUCLEIC ACID.|
    US6468740B1|1992-11-05|2002-10-22|Affymetrix, Inc.|Cyclic and substituted immobilized molecular synthesis|
    US5424186A|1989-06-07|1995-06-13|Affymax Technologies N.V.|Very large scale immobilized polymer synthesis|
    US5744101A|1989-06-07|1998-04-28|Affymax Technologies N.V.|Photolabile nucleoside protecting groups|
    US6379895B1|1989-06-07|2002-04-30|Affymetrix, Inc.|Photolithographic and other means for manufacturing arrays|
    US6309822B1|1989-06-07|2001-10-30|Affymetrix, Inc.|Method for comparing copy number of nucleic acid sequences|
    US5800992A|1989-06-07|1998-09-01|Fodor; Stephen P.A.|Method of detecting nucleic acids|
    US5925525A|1989-06-07|1999-07-20|Affymetrix, Inc.|Method of identifying nucleotide differences|
    US6346413B1|1989-06-07|2002-02-12|Affymetrix, Inc.|Polymer arrays|
    US6919211B1|1989-06-07|2005-07-19|Affymetrix, Inc.|Polypeptide arrays|
    US6506558B1|1990-03-07|2003-01-14|Affymetrix Inc.|Very large scale immobilized polymer synthesis|
    US6955915B2|1989-06-07|2005-10-18|Affymetrix, Inc.|Apparatus comprising polymers|
    US5143854A|1989-06-07|1992-09-01|Affymax Technologies N.V.|Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof|
    US6551784B2|1989-06-07|2003-04-22|Affymetrix Inc|Method of comparing nucleic acid sequences|
    US6406844B1|1989-06-07|2002-06-18|Affymetrix, Inc.|Very large scale immobilized polymer synthesis|
    US5232829A|1989-09-29|1993-08-03|Hoffmann-La Roche Inc.|Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes|
    CA2039517C|1990-04-03|2006-11-07|David Segev|Dna probe signal amplification|
    US5071962A|1990-05-31|1991-12-10|The United State Of America As Represented By The Department Of Health And Human Services|Nucleotide, deduced amino acid sequence, isolation and purification of heat-shock chlamydial proteins|
    DE69112309T2|1990-06-28|1996-01-25|Wakunaga Seiyaku Kk|Procedure for nucleic acid detection.|
    US5645994A|1990-07-05|1997-07-08|University Of Utah Research Foundation|Method and compositions for identification of species in a sample using type II topoisomerase sequences|
    GB2262987A|1990-09-21|1993-07-07|Imp Cancer Res Tech|Identification of organisms|
    GB9020621D0|1990-09-21|1990-10-31|Imp Cancer Res Tech|Identification of organisms|
    WO1992010588A1|1990-12-06|1992-06-25|Affymax Technologies N.V.|Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides|
    US5437976A|1991-08-08|1995-08-01|Arizona Board Of Regents, The University Of Arizona|Multi-domain DNA ligands bound to a solid matrix for protein and nucleic acid affinity chromatography and processing of solid-phase DNA|
    US6706473B1|1996-12-06|2004-03-16|Nanogen, Inc.|Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides|
    US6652808B1|1991-11-07|2003-11-25|Nanotronics, Inc.|Methods for the electronic assembly and fabrication of devices|
    US6048690A|1991-11-07|2000-04-11|Nanogen, Inc.|Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis|
    US6569382B1|1991-11-07|2003-05-27|Nanogen, Inc.|Methods apparatus for the electronic, homogeneous assembly and fabrication of devices|
    US20040086917A1|1995-09-27|2004-05-06|Nanogen, Inc.|Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis|
    US5556961A|1991-11-15|1996-09-17|Foote; Robert S.|Nucleosides with 5'-O-photolabile protecting groups|
    EP0916396B1|1991-11-22|2005-04-13|Affymetrix, Inc. |Combinatorial strategies for polymer synthesis|
    US6849462B1|1991-11-22|2005-02-01|Affymetrix, Inc.|Combinatorial strategies for polymer synthesis|
    US6943034B1|1991-11-22|2005-09-13|Affymetrix, Inc.|Combinatorial strategies for polymer synthesis|
    CA2124795A1|1991-12-23|1993-07-08|Ray Sanchez-Pescador|Chlamydiae probes for use in solution phase sandwich hybridization assays|
    JPH07502655A|1991-12-23|1995-03-23|
    US5583211A|1992-10-29|1996-12-10|Beckman Instruments, Inc.|Surface activated organic polymers useful for location - specific attachment of nucleic acids, peptides, proteins and oligosaccharides|
    US7713528B1|1993-02-18|2010-05-11|Enzo Therapeutics, Inc.|Method for in vivo delivery of active compounds using reagent conjugate|
    EP0787183A4|1993-07-23|1998-05-27|Hyseq Inc|Method for screening unknown organisms|
    FR2710075B1|1993-09-15|1995-10-27|Bio Merieux|Reagent and method for the detection of a nucleotide sequence with signal amplification.|
    US6315953B1|1993-11-01|2001-11-13|Nanogen, Inc.|Devices for molecular biological analysis and diagnostics including waveguides|
    US6051380A|1993-11-01|2000-04-18|Nanogen, Inc.|Methods and procedures for molecular biological analysis and diagnostics|
    US7101661B1|1993-11-01|2006-09-05|Nanogen, Inc.|Apparatus for active programmable matrix devices|
    US6017696A|1993-11-01|2000-01-25|Nanogen, Inc.|Methods for electronic stringency control for molecular biological analysis and diagnostics|
    US6375899B1|1993-11-01|2002-04-23|Nanogen, Inc.|Electrophoretic buss for transport of charged materials in a multi-chamber system|
    US6403367B1|1994-07-07|2002-06-11|Nanogen, Inc.|Integrated portable biological detection system|
    US20040077074A1|1993-11-01|2004-04-22|Nanogen, Inc.|Multi-chambered analysis device|
    US6068818A|1993-11-01|2000-05-30|Nanogen, Inc.|Multicomponent devices for molecular biological analysis and diagnostics|
    US6726880B1|1993-11-01|2004-04-27|Nanogen, Inc.|Electronic device for performing active biological operations and method of using same|
    US6287517B1|1993-11-01|2001-09-11|Nanogen, Inc.|Laminated assembly for active bioelectronic devices|
    US6254827B1|1993-11-01|2001-07-03|Nanogen, Inc.|Methods for fabricating multi-component devices for molecular biological analysis and diagnostics|
    US5849486A|1993-11-01|1998-12-15|Nanogen, Inc.|Methods for hybridization analysis utilizing electrically controlled hybridization|
    US6331274B1|1993-11-01|2001-12-18|Nanogen, Inc.|Advanced active circuits and devices for molecular biological analysis and diagnostics|
    US5632957A|1993-11-01|1997-05-27|Nanogen|Molecular biological diagnostic systems including electrodes|
    US6309602B1|1993-11-01|2001-10-30|Nanogen, Inc.|Stacked, reconfigurable system for electrophoretic transport of charged materials|
    US7857957B2|1994-07-07|2010-12-28|Gamida For Life B.V.|Integrated portable biological detection system|
    US7582421B2|1993-11-01|2009-09-01|Nanogen, Inc.|Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip|
    US6225059B1|1993-11-01|2001-05-01|Nanogen, Inc.|Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnostics|
    US5605662A|1993-11-01|1997-02-25|Nanogen, Inc.|Active programmable electronic devices for molecular biological analysis and diagnostics|
    US6319472B1|1993-11-01|2001-11-20|Nanogen, Inc.|System including functionally separated regions in electrophoretic system|
    US6638482B1|1993-11-01|2003-10-28|Nanogen, Inc.|Reconfigurable detection and analysis apparatus and method|
    US7172864B1|1993-11-01|2007-02-06|Nanogen|Methods for electronically-controlled enzymatic reactions|
    US6287850B1|1995-06-07|2001-09-11|Affymetrix, Inc.|Bioarray chip reaction apparatus and its manufacture|
    DE69527585T2|1994-06-08|2003-04-03|Affymetrix Inc|Method and device for packaging chips|
    US7378236B1|1994-06-17|2008-05-27|The Board Of Trustees Of The Leland Stanford Junior University|Method for analyzing gene expression patterns|
    US7323298B1|1994-06-17|2008-01-29|The Board Of Trustees Of The Leland Stanford Junior University|Microarray for determining the relative abundances of polynuceotide sequences|
    US5807522A|1994-06-17|1998-09-15|The Board Of Trustees Of The Leland Stanford Junior University|Methods for fabricating microarrays of biological samples|
    US6306657B1|1994-06-28|2001-10-23|Kalyx Biosciences, Inc.|Polynucleotide probe and kit for amplifying signal detection in hybridization assays|
    US6121048A|1994-10-18|2000-09-19|Zaffaroni; Alejandro C.|Method of conducting a plurality of reactions|
    US8236493B2|1994-10-21|2012-08-07|Affymetrix, Inc.|Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA|
    US6720149B1|1995-06-07|2004-04-13|Affymetrix, Inc.|Methods for concurrently processing multiple biological chip assays|
    US6040138A|1995-09-15|2000-03-21|Affymetrix, Inc.|Expression monitoring by hybridization to high density oligonucleotide arrays|
    EP0880598A4|1996-01-23|2005-02-23|Affymetrix Inc|Nucleic acid analysis techniques|
    US6297006B1|1997-01-16|2001-10-02|Hyseq, Inc.|Methods for sequencing repetitive sequences and for determining the order of sequence subfragments|
    US20020042048A1|1997-01-16|2002-04-11|Radoje Drmanac|Methods and compositions for detection or quantification of nucleic acid species|
    US6309824B1|1997-01-16|2001-10-30|Hyseq, Inc.|Methods for analyzing a target nucleic acid using immobilized heterogeneous mixtures of oligonucleotide probes|
    US6326489B1|1997-08-05|2001-12-04|Howard Hughes Medical Institute|Surface-bound, bimolecular, double-stranded DNA arrays|
    DE19741715A1|1997-09-22|1999-03-25|Hoechst Ag|New pentopyranosyl nucleoside compounds|
    WO1999019510A1|1997-10-10|1999-04-22|President And Fellows Of Harvard College|Surface-bound, double-stranded dna protein arrays|
    US6485944B1|1997-10-10|2002-11-26|President And Fellows Of Harvard College|Replica amplification of nucleic acid arrays|
    US6511803B1|1997-10-10|2003-01-28|President And Fellows Of Harvard College|Replica amplification of nucleic acid arrays|
    EP1028970A1|1997-10-10|2000-08-23|President And Fellows Of Harvard College|Replica amplification of nucleic acid arrays|
    AU746061B2|1997-12-12|2002-04-11|Qiagen Gaithersburg, Inc.|Assessment of human papilloma virus-related disease|
    US6355419B1|1998-04-27|2002-03-12|Hyseq, Inc.|Preparation of pools of nucleic acids based on representation in a sample|
    US7314708B1|1998-08-04|2008-01-01|Nanogen, Inc.|Method and apparatus for electronic synthesis of molecular structures|
    US6232067B1|1998-08-17|2001-05-15|The Perkin-Elmer Corporation|Adapter directed expression analysis|
    US6545264B1|1998-10-30|2003-04-08|Affymetrix, Inc.|Systems and methods for high performance scanning|
    US7612020B2|1998-12-28|2009-11-03|Illumina, Inc.|Composite arrays utilizing microspheres with a hybridization chamber|
    AU4025300A|1999-03-24|2000-10-09|Packard Bioscience Company|Continuous porous matrix arrays|
    JP2004500020A|1999-03-30|2004-01-08|ナノゲン・インコーポレイテッド|Discrimination of Single Nucleotide Polymorphisms by Electronic Dot Blot Assay on Semiconductor Microchip|
    AT504937T|1999-04-27|2011-04-15|Bio Rad Laboratories|SAMPLE HOLDER FOR A GAS PHASEASE SPECTROMETER|
    US20030096321A1|1999-05-19|2003-05-22|Jose Remacle|Method for the identification and/or the quantification of a target compound obtained from a biological sample upon chips|
    EP1054259A1|1999-05-19|2000-11-22|Remacle, José|Method for the identification of a target compound|
    US6465183B2|1999-07-01|2002-10-15|Agilent Technologies, Inc.|Multidentate arrays|
    JP2001017166A|1999-07-02|2001-01-23|Fuji Photo Film Co Ltd|Dna chip, verifying kit of dna chip and verification of dna chip|
    US6428957B1|1999-11-08|2002-08-06|Agilent Technologies, Inc.|Systems tools and methods of assaying biological materials using spatially-addressable arrays|
    US6235483B1|2000-01-31|2001-05-22|Agilent Technologies, Inc.|Methods and kits for indirect labeling of nucleic acids|
    US8076063B2|2000-02-07|2011-12-13|Illumina, Inc.|Multiplexed methylation detection methods|
    EP1481076A4|2001-07-12|2005-05-11|Illumina Inc|Multiplex nucleic acid reactions|
    US7955794B2|2000-09-21|2011-06-07|Illumina, Inc.|Multiplex nucleic acid reactions|
    US6455007B1|2000-06-13|2002-09-24|Symyx Technologies, Inc.|Apparatus and method for testing compositions in contact with a porous medium|
    US7601497B2|2000-06-15|2009-10-13|Qiagen Gaithersburg, Inc.|Detection of nucleic acids by target-specific hybrid capture method|
    US7439016B1|2000-06-15|2008-10-21|Digene Corporation|Detection of nucleic acids by type-specific hybrid capture method|
    US6905816B2|2000-11-27|2005-06-14|Intelligent Medical Devices, Inc.|Clinically intelligent diagnostic devices and methods|
    ES2593683T3|2001-03-09|2016-12-12|Trovagene, Inc.|Conjugated probes and optical analyte detection|
    US7582420B2|2001-07-12|2009-09-01|Illumina, Inc.|Multiplex nucleic acid reactions|
    US6893822B2|2001-07-19|2005-05-17|Nanogen Recognomics Gmbh|Enzymatic modification of a nucleic acid-synthetic binding unit conjugate|
    US7601493B2|2002-07-26|2009-10-13|Nanogen, Inc.|Methods and apparatus for screening and detecting multiple genetic mutations|
    US20040241659A1|2003-05-30|2004-12-02|Applera Corporation|Apparatus and method for hybridization and SPR detection|
    US7622281B2|2004-05-20|2009-11-24|The Board Of Trustees Of The Leland Stanford Junior University|Methods and compositions for clonal amplification of nucleic acid|
    US7828954B2|2004-09-21|2010-11-09|Gamida For Life B.V.|Electrode based patterning of thin film self-assembled nanoparticles|
    US7314542B2|2004-09-23|2008-01-01|Nanogen, Inc.|Methods and materials for optimization of electronic transportation and hybridization reactions|
    US20060246576A1|2005-04-06|2006-11-02|Affymetrix, Inc.|Fluidic system and method for processing biological microarrays in personal instrumentation|
    WO2006121888A2|2005-05-06|2006-11-16|Gen-Probe Incorporated|Methods of nucleic acid target capture|
    WO2007070553A2|2005-12-12|2007-06-21|The Johns Hopkins University|Double-tiled and multi-tiled arrays and methods thereof|
    JP2009522281A|2005-12-28|2009-06-11|トランスレーショナルセラピューティクス，インク．|Treatment based on translational dysfunction|
    US20080003667A1|2006-05-19|2008-01-03|Affymetrix, Inc.|Consumable elements for use with fluid processing and detection systems|
    NZ576149A|2006-09-29|2012-06-29|Translational Therapeutics Inc|Eif4e regulon-based diagnostics|
    EP1912067A1|2006-10-12|2008-04-16|Eppendorf Array Technologies S.A.|Method for quantification of a target compound obtained from a biological sample upon chips|
    US9938641B2|2006-12-18|2018-04-10|Fluidigm Corporation|Selection of aptamers based on geometry|
    WO2008085777A2|2007-01-03|2008-07-17|Xgenetics Inc.|A method for early detection of cancer|
    US8877436B2|2008-10-27|2014-11-04|Qiagen Gaithersburg, Inc.|Fast results hybrid capture assay on an automated platform|
    CA2750338C|2009-01-28|2019-06-25|Qiagen Gaithersburg, Inc.|Sequence-specific large volume sample preparation method and assay|
    CA2760542A1|2009-05-01|2010-11-04|Qiagen Gaithersburg, Inc.|A non-target amplification method for detection of rna splice-forms in a sample|
    JP5826752B2|2009-09-14|2015-12-02|キアジェン ゲイサーズバーグ インコーポレイテッド|Compositions and methods for recovering nucleic acids or proteins from tissue samples fixed in cytological media|
    AU2011210734B2|2010-01-29|2017-02-09|Qiagen Gaithersburg, Inc.|Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids|
    JP2013517803A|2010-01-29|2013-05-20|キアジェンゲイサーズバーグインコーポレイテッド|Method for determining and confirming the presence of HPV in a sample|
    CA2799200A1|2010-05-19|2011-11-24|Qiagen Gaithersburg, Inc.|Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids|
    EP2576840B1|2010-05-25|2018-10-17|QIAGEN Gaithersburg, Inc.|Fast results hybrid capture assay and associated strategically-truncated probes|
    JP2014511182A|2011-02-24|2014-05-15|キアゲンガイサーズバーグアイエヌシー．|Materials and methods for detecting HPV nucleic acids|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    FI840655A|FI71768C|1984-02-17|1984-02-17|Enhanced nucleic acid reagents and process for their preparation.|
    [返回顶部]